期刊文献+

磷酸川芎嗪微孔渗透泵游离膜扩散动力学研究及其处方优化 被引量:1

Study on Diffusion Kinetics of Tetramethylpyrazine Phosphate Through Free Coating Film of Controlled Porosity Osmotic Pump Tablets and Formulation Optimization
原文传递
导出
摘要 目的以磷酸川芎嗪为模型,拟合适用于微孔渗透泵控释片的经验公式,用于预测不同包衣膜处方下药物释放速度并优化磷酸川芎嗪微孔渗透泵控释片处方。方法用游离膜扩散动力学方法,研究不同包衣液处方、游离膜厚度、溶液黏度与药物扩散速度的函数关系。用均匀设计优化磷酸川芎嗪微孔渗透泵处方。结果以理论的经典公式为原型,以实验数据为根据拟合出适用于微孔渗透泵控释片的经验公式。用均匀设计软件处理磷酸川芎嗪微孔渗透泵释药数据,得到回归方程和优化处方,F检验显示回归方程显著有效,相关系数超过0.99。结论拟合得到的经验公式能很好的预测药物的释放速度,能为进一步研究提供指导。最优处方药物释放均一性、重现性良好,符合零级释药规律,12 h药物释放90%以上。 OBJECTIVE To deduce a modified empirical formula for predicting the release rate of drugs through different coating formulations of controlled porosity osmotic pump tablets (CPOP) using etramethylpyrazine phosphate (TMPP) as a model drug and to optimize the formulation of TMPP CPOP. METHODS The functions between drug release and coating formulation, film thickness and viscosity were studed by using free film diffusion equipment. Uniform design was adopted to optimize formulation. RESULTS Based on the theoretical formula and actual experimental data, the modified empirical formula which fit for controlled porosity osmotic pump tablets had been deduced. Regression equation and the best formulation were calculated by uniform design software. F test indicated that the regression equation was significant,and the linear correlation coefficient exceeded 0. 99. CONCLUSION The modified empirical formula can accurately predict the drug diffusion rate in different conditions, thus it can provide useful information for filrther study. The cumulative release of the best formulation exceeds 90% at 12 h with good reproducibility and conforms to zero order rate.
出处 《中国药学杂志》 CAS CSCD 北大核心 2011年第17期1334-1339,共6页 Chinese Pharmaceutical Journal
关键词 磷酸川芎嗪 微孔渗透泵 均匀设计 公式拟合 处方优化 tetramethlprazine phosphate (TMPP) controlled porosity osmotic pump tablets (CPOP) uniform design formula fitting formulation optimization
  • 相关文献

参考文献10

  • 1LIU H,YANG X G,NIE S F,et al. Chitosan-based controlled po- rosity osmotic pump for colon-specific delivery system: Screening of formulation variables and in vitro investigation [ J ]. Int J Pharm, 2007,332 ( 1-2 ) : 115-124.
  • 2GAYLEN M Z, GREGORY A M,STEVEN C S. Controlled po- rosity solubility-and resin-modulated osmotic drug delivery sys- tems for release of dihiazem hydrochloride [ J ]. J Controlled Re- lease,1991,16(1-2) : 237-244.
  • 3GAYLEN M Z,GERALD S R,KENNETH I H. OSMOTIC FLOW THROUGH CONTROLLED POROSITY FILMS : AN AP- PROACH TO DELIVERY OF WATER SOLUBLE COMPOUNDS [ J]. J Controlled Release, 1985,2 : 217-229.
  • 4RAJAN K V, ADITYA M K, SAN JAY G. Development and eval- uation of extended release formulations of isosorbide mononitrate based on osmotic technology [ J]. Int J Pharm ,2003,263 ( 1-2 ) : 9 -24.
  • 5RAJAN K V, SANJAY G. Development and evaluation of osmoti- cally controlled oral drug delivery system of glipizide [ J ]. Int J Pharm,2004,57 ( 3 ) : 513-525.
  • 6GUO J H,RICHARD E R,GORDON L A. An investigation into the mechanical and transport of aqueous latex films: A new hy- pothesis for the film-forming mechanism of aqueous dispersion system[ J]. Pharm Res, 1993,10(3 ) : 405-410.
  • 7MARIAGRAZIA M, GERT R, ANDERS A. Electronic speckle pattern interferometry:A novel non-invasive tool for studying drug transport rate through free films [ J ]. J Controlled Release, 2006, 114(3 ) :369-380.
  • 8MAARIT T, RIITTA S, SOILI P, et al. Enhanced film-forming properties for ethyl cellulose and starch acetate using n-alkenyl succinic anhydrides as novel plasticizers [ J ]. Eur J Pharm Sci, 2003,19(5) :363-371.
  • 9AVINASH G T, GAYLEN M Z, KENNETH J H. Mechanism of water transport in controlled porosity osmotic devices[ J]. J Mem- br Sci,1989,40(3) : 279-310.
  • 10SUN Y M, HUANG W F, CHANG C C. Spray-coated and solu- tion-cast ethylcellulose pseudolatex membranes [ J ]. J Membr Sci,1999,157(2) :159-170.

同被引文献3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部